Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses
Invezz
Novavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the company’s fiscal Q1 2024 earnings..
Novavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the company’s fiscal Q1 2024 earnings..
*Alstom FY 2023/24 Free cash flow at €(557) million following strong €562 million Free cash flow generation in the second half..
*FIRST-QUARTER 2024 RESULTS*
Press release
Paris, 07/05/2024
· *Group outlook for 2024..